Tulane Professor Offers Personal Account Of COVID-19 Vaccine Trial
Tulane University history professor Walter Isaacson was one of 44,000 individuals to participate in Pfizer Inc.'s (NYSE: PFE) COVID-19 vaccine trial, and the process was "pretty easy," he said during a Tuesday morning